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ABSTRACT 
During human placentation an alterable cell type emerges, the human trophoblast, fulfilling a wide 
range of tasks. The trophoblast can choose between two pathways, becoming a villous trophoblast 
responsible for hormone production, nutrition of the fetus and gas exchange, or pursue the path of 
becoming an extravillous trophoblast, invading the maternal tissue for immunological adaptation, 
mechanic anchorage and vascular remodelling. For all research of the latter the main mechanisms 
controlling the differentiation pathways regulating trophoblast invasion abide poorly understood.  
During my thesis I investigated the involvement of signaling pathways in trophoblast 
invasion and migration: on one hand the Wnt (Wingless) pathway, a complex network of signaling 
cascades best known for their roles in embryogenesis, normal physiological and pathological 
processes and on the other hand the phosphatidylinositol-3-kinase (PI3K)/AKT pathway 
consisting of a wide variety of intracellular signal transducer enzymes liable for the promotion of 
cell growth, motility and inhibition of apoptotic cascades. 
First, I investigated the expression pattern of human Wnt ligands and their frizzled (FZD) 
receptors in different trophoblast model systems and in human placental tissue from first to third 
trimester. 14 out of 19 Wnt ligands and 8 out of 10 FZD receptors were expressed plus the pattern 
of ligands and receptors varied with gestational age and different trophoblast subtypes. These data 
suggested cell-specific functions in morphogenesis and motility. Moreover, an antagonizing effect 
of canonical and non-canonical signaling could be observed in the SGHPL-5 trophoblast cell line. 
Recent studies link PI3K/AKT signaling to active Wnt signaling. Therefore I explored the 
potential cross-talk between these two signaling cascades. For mimicking active Wnt signaling, I 
stimulated trophoblast cells with recombinant Wnt-3A and was interested in the outcome on the 
transcriptional level and the influence on motility. Blocking of Wnt-3A activated signaling with 
recombinant Dickkopf-1 (Dkk1) showed no alteration of the phosphorylation status of PI3K/AKT 
components and inhibition with a chemical inhibitor (LY294002) of PI3K/AKT had no influence 
on nuclear β-catenin levels, respectively. However, both pathways promoted Wnt-dependent 
migration and the release of matrix metalloproteinase-2 (MMP-2), which has been identified as 
novel Wnt target in invasive trophoblasts.  
Nevertheless, Wnt ligands are not the only factors which could promote trophoblast 
motility. The human pregnancy hormone, human chorionic gonadotropin (hCG), which controls 
implantation, decidualization, and placental development, was also shown to regulate invasion and 
migration in villous explant cultures and SGHPL-5 cells through activation of signaling cascades 
like PI3K/AKT and extracellular regulated kinase (ERK) signaling. 
Zusammenfassung 
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ZUSAMMENFASSUNG 
In der menschlichen Plazentation rückt ein Zelltyp in den Vordergrund, der Trophoblast, denn ihm 
fallen in diesem Prozess die wichtigsten Aufgaben zu. Der Trophoblast kann während seiner 
Entwicklung zwischen zwei Pfaden wählen, er kann sich in einen villösen Trophoblast 
verwandeln, verantwortlich für die Hormonproduktion, die Nährstoffversorgung des Fötus und 
den Gasaustausch, oder er kann sich zu einem extravillösen Trophoblasten entwickeln, ins 
mütterliche Gewebe einwandern und für die immunologische sowie die Blutgefäßanpassung 
sorgen. Und hier sind, trotz vieler Bemühungen der letzten Zeit, viele Fragen offen. 
Während meiner Dissertation lag mein Hauptaugenmerk auf Signalkaskaden, die im 
Zusammenhang mit trophoblastärer Differenzierung und Invasion stehen oder stehen könnten. 
Zwei dieser Signalwege interessierten mich am meisten: der Wnt-Signalweg, mit wichtigen 
Funktionen in der Embryogenese, in physiologischen Prozessen und in der Karzinogenese, und 
der Phosphatidylinositol 3-kinase (PI3K)/AKT Signalweg, bestehend aus einer Vielzahl von 
Signaltransduktions-Enzymen, die beim Zellwachstum, der Motilität und bei Apoptose-
hemmenden Kaskaden eine Rolle spielen. Als erstes untersuchte ich das Expressionsmuster der 
humanen Wnt Liganden und deren FZD Rezeptoren in unterschiedlichen Plazentageweben, vom 
ersten bis zum dritten Trimester und in Trophoblastmodellsystemen. Ich konnte zeigen, dass 14 
von 19 Wnt Liganden und 8 von 10 FZD Rezeptoren in der Plazenta exprimiert werden, und dass 
sich das Expressionsmuster der Liganden und Rezeptoren, abhängig vom Gestationsalter, in den 
unterschiedlichen trophoblastären Subtypen änderte. Des Weiteren konnte ich antagonistische 
Effekte zwischen kanonischen und nicht-kanonischen Wnt Signalwegen in der trophoblastären 
Zelllinie SGHPL-5 nachweisen. Diese Beobachtungen ließen den Schluss zu, dass die Wnt 
Signalkaskade eine Rolle in der Morphogenese und Invasion spielen könnte. Neueste Studien 
zeigen einen Brückenschlag zwischen dem Wnt und PI3K/AKT Signalweg, und mich interessiert 
ob dieser cross-talk auch in der Plazenta stattfindet. Um Einflüsse auf transkriptioneller Ebene 
und/oder auf die Mobilät zu untersuchen, stimulierte ich Trophoblastenzellen mit dem 
rekombinanten Liganden Wnt-3A. Mit Hilfe von Blockierungsstudien nach erfolgter Stimulierung 
konnte keine direkte Einflussnahme auf den jeweils anderen Signalweg festgestellt werden. 
DKK1, ein rekombinanter Wnt Inhibitor, konnte die Phosphorylierung von AKT nicht verhindern. 
Und umgekehrt führte die Blockierung des PI3K/AKT Signalweges mit einem chemischen 
Inhibitor zu keiner Abnahme der Translokation von β-catenin in den Kern. Dennoch begünstigten 
beide Signalwege die Wnt-abhängige Zellmotilität und beide regulierten die Ausschüttung der 
Matrix Metalloproteinase-2 (MMP-2), welche als neues Zielprotein der Wnt-Kaskade im 
Trophoblasten identifiziert wurde. 
Zusammenfassung 
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Die Liganden des Wnt Signalwegs sind jedoch nicht die einzigen Faktoren, die zu einer höheren 
Mobilität von Trophoblastenzellen führen. Es konnte ebenfalls gezeigt werden, dass das 
Schwangerschaftshormon Chorionic Gonadotropin (hCG), welches während der Implantation, der 
Dezidualisierung und der Plazentation eine sehr wichtige Rolle spielt, die Migration und Invasion 
von Trophoblasten durch die Signalwege PI3K/AKT und Extracellular Regulated Kinase (ERK) 
steuern kann. 
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1. INTRODUCTION 
1.1 GENERAL INTRODUCTION 
1.1.1 Human placentation 
The human placenta, a unique and specialized organ with a distinct lifetime, is functional only 
during the short period of pregnancy. It occupies a fundamental role during embryonic 
development in mammals. Necessary for gas transfer, nutrition, excretory and immunological 
functions, the placenta is the connector between mother and unborn child. It is crucial for the 
growth and survival of the embryo. 
Within this framework it becomes critically important to understand placental development 
at a cellular level. The placenta emerges from an epithelial layer, called trophectoderm which is 
the result of the first division in extraembryonic and embryonic tissue (trophectoderm and inner 
cell mass; ICM). The essentials in brief, after fertilization and a series of cell division, the oocyte 
develops into a ball of totipotent cells, called morula. These events take place in the oviduct. 
Following compaction of the morula (approximately between day 3 and 4 after fertilisation) the 
first differentiation event occurs by formation of the blastocyst into trophectoderm and ICM. At 
this stage the cells of the blastocyst are no longer totipotent (Cauffman et al., 2009)(Figure 1). 
The trophectoderm, a simple epithelium of trophoblast cells, will not contribute any tissue to the 
embryo, subsequently. It represents the precursor cell pool of the trophoblast lineage. 
 
 
 
Figure 1 | Following 
fertilization in the 
oviduct, the embryo 
undergoes several 
rounds of cell division, 
forming the morula. At 
the late morula stage, the 
embryo enters the 
uterine lumen and 
transforms into a 
blastocyst that contains a 
cavity (called blastocoel) 
with two different cell 
populations, the inner 
cell mass and the 
trophectoderm (the pro-
genitor of trophoblast 
cells). (Wang and Dey, 
2006) 
 
The next event takes place when the blastocyst attaches to endometrium of the uterus, usually 
termed as blastocyst implantation (Figure 2A). This can be seen as the initial step of placentation 
1. Introduction 
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and the birth of the first trophoblast stem cell population. Recent studies suggest that L-selectin 
and its ligand may have a predominant role as factors mediating the initial adhesion of human 
blastocysts to the uterine epithelia (Genbacev et al., 2003). Also trophinin has been identified as a 
unique cell adhesion molecule involved in the initial adhesion to the endometrial surface (Fukuda 
and Sugihara, 2008). 
Once the blastocyst is attached to the endometrium, the development of the different 
trophoblast subpopulations takes place (Figure 2B). On the embryonic side, the ICM differentiate 
into the epiblast, the future embryonic germ layers, and the hypoblast, forming the extraembryonic 
endoderm (transient yolk sac). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 | A The placenta begins to form when the blastocyst 
implants into the uterus. Once the blastocyst has found the 
optimal site for implantation, the trophectoderm adheres to the 
uterine wall. B About six days after ovulation, the blastocyst 
starts sinking into the decidua initiating implantation. During 
this process the syncytiotrophoblast starts to penetrate the 
uterine epithelium. Ten days after ovulation the embryo is 
completely embedded into the decidua, and formation and 
differentiation of the embryo and placenta takes place. The 
uterine endometrium at this stage is called decidua. 
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1.2 DIFFERENTIATION OF HUMAN TROPHOBLASTS 
1.2.1 Basic aspects of trophoblast lineage development 
After anchoring and implantation of the blastocyst, the trophoblast stem cells will start to develop 
into several trophoblast subtypes. The cells of the trophoblast lineage cover a variety of different 
functions including hormone production, immunological adaptation, mechanic anchorage, 
vascular connection to the circulation of the mother, nutrition of the fetus and gas exchange. To 
cope with these different functions the cytotrophoblast (trophoblast progenitor cells) can either 
develop into an invasive or a non-invasive phenotype (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 | Simplified overview of cyto-
trophoblast lineage development. 
 
The basic structure of the human placenta, a haemochorial placenta, is formed within the first 
three weeks of pregnancy. This includes floating and anchoring villi and its specific cell types, the 
syncytiotrophoblast and the invasive extravillous trophoblast (EVT). The syncytiotrophoblast, 
covering the numerous chorionic villi, which are surrounded by maternal blood, arises by fusion 
of the underlying villous cytotrophoblast and is building a natural barrier between mother and 
fetus. This multinucleated epithelium, also called syncytium, is carrying out two main functions 
(Figure 3, 4A). On one hand the syncytium is responsible for transport of nutrients and gases from 
the mother to the fetus and vice versa (waste products of the fetus), and on the other hand it 
produces hormones necessary for successful progression of pregnancy. Hormones such as hCG 
(human chorionic gonadotropin), PL (placental lactogen) or PGH (placental growth hormone) are 
necessary for diverse functions of the placenta like placental growth or maternal adaptation to 
pregnancy (Gude et al., 2004).  
1. Introduction 
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1.2.2 Extravillous trophoblast differentiation 
At discrete sites, the CTB proliferate and build cell columns (CC), which anchor the developing 
placenta to the uterine wall. These cell columns give rise to the second branch of trophoblasts, the 
invasive EVTs (Figure 4A, B). The EVT of the CC consist of proximal proliferative and distal 
non-cycling, highly invasive cells. During this process, a multitude of pattern changes, from basic 
transcriptional regulation to variances in the expression of cell surface proteins and/or proteases. 
 
 
Figure 4 | Formation and differentiation of EVTs. A CTB stem cells fuse to form the multinucleated syncytium (S) in 
floating villi surrounded by maternal blood. After anchorage of a placental villous at the uterine basement membrane 
cytotrophoblast (CTB) stem cells give rise to proliferative cell columns (CC). At distal sites non-proliferating, EVTs 
are formed which detach from the cell columns and migrate into stromal areas of the maternal decidua (formation of 
EVTs. EVT differentiate to giant cells (GC) in deeper areas of the placental bed. B Endovascular trophoblasts (ETB), 
which play a role in remodelling of the vasculature, migrate into spiral arteries, replace the maternal endothelium and 
acquire molecular characteristics of endothelial cells.  
 
One of the most distinct changes in transcriptional regulation is the upregulation of the 
transcription factor TCF-4 (T cell-specific factor) and at the same time, to some extent the 
translocation of β-catenin into the nucleus, both factors indicating an involvement of Wnt-
signaling during the process of EVT differentiation and invasion. Upon invading the decidua, the 
EVT have also to cope with the ECM (extracellular matrix) of the maternal uterus, which is 
composed of structural and regulatory molecules including laminin, collagens and fibronectin 
(Chen and Aplin, 2003). Indeed, EVTs express a variety of specific cell surface receptors that bind 
to ECM proteins (Ruoslahti, 1996). The most prominent ones are from the integrin family 
(Stupack and Cheresh, 2002). They belong to a large class of hetero-dimeric transmembrane 
glycoproteins composed of different α- and β-subunits. Differentiation from CTB to EVT is 
accompanied by switching of integrin expression. During the first trimester of pregnancy α6β4 
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integrins are restricted to villous CTBs only, whereas when they undergo differentiation, α6β4 
integrins expression diminishes and α5β1 and α1β1 integrins are upregulated (Damsky et al., 
1992). These changes in integrin expression are thought to enable EVTs to achieve an invasive 
phenotype, or in other words, the exchange of integrins facilitates EVT migration and invasion.  
Proteases are also essential for cellular migration and invasion, they enable cells to detach 
from basement membranes (BM) and are involved in the degradation of the ECM. During the 
lifespan of an EVT, it has to undergo two detaching processes, at the villous BM and at the distal 
CC (Graham and Lala, 1992), and has to overcome the decidual barrier to reach its destination. 
Several proteases have been identified to play roles in theses processes (Bischof and Irminger-
Finger, 2005). Two of them, the gelatinases matrix metallo proteinase-2 and -9 play major roles in 
trophoblast migration and invasion. Depth  of invasion into the maternal decidua is partly 
controlled by endometrial expression of their inhibitors (TIMPs, tissue inhibitors of 
metalloproteinases). 
Furthermore, there is evidence for the importance of the serine protease urokinase-type 
plasminogen activator (uPA) system during trophoblast invasion. Our laboratory could show that 
TNF-α-induced inhibiton of trophoblast migration/invasion is mediated via upregulation of the 
uPA-specific inhibitor plasminogen activator inhibitor-1 (PAI-1) (Bauer et al., 2004; Huber et al., 
2006). But not only transcription factors, matrix proteins and proteases have an influence on the 
invasive properties of EVTs. There is a huge bunch of growth factors regulating EVT migratory 
behaviour in an auto- and paracrine manner (Bischof et al., 2000; Ferretti et al., 2007). 
Proliferation and/or migration/invasion of trophoblasts can be stimulated by growth factors such 
as epidermal growth factor (EGF), hepatocyte growth factor (HGF) or insulin-growth factor I/II 
(IGF-I/II) (Bass et al., 1994; Cartwright et al., 1999; Hamilton et al., 1998). Using different 
trophoblast model systems it was demonstrated that the majority of these growth factors act 
through signaling cascades, namely extracellular signal-regulated kinases (ERKs), Janus kinase-
signal transducers and activators of transcription (Jak/Stat) and the phosphoinositide 3-
kinase/PI3K/AKT signaling pathways (Fitzgerald et al., 2005; Pollheimer and Knofler, 2005). 
 And last but not least, there are physiological factors which are playing important roles in 
EVT differentiation. During the first trimester of pregnancy physiological hypoxia (app. 2% O2) 
can be detected in the placental bed. In this hypoxic environment proliferation takes place, at the 
tips of the anchoring villi. Approaching the uterine arterioles (Figure 4B), hypoxia changes to 
normoxia, and this gradient in oxygen levels promotes trophoblasts invasion by inducing cell 
cycle arrest (Genbacev et al., 1996). The question, why EVT extensively invade the arterial rather 
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than the venous side of the uterine circulation, may be explained by oxygen gradient as well as by 
the different expression of the ephrin system (Red-Horse et al., 2005). 
 
 
1.3 HORMONAL INFLUENCE ON TROPHOBLAST DIFFERENTIATION 
1.3.1 Human Chorionic Gonadotropin/ β-hCG (β-subunit) 
Human chorionic gonadotropin, a member of the family of glycoprotein hormones, is composed of 
a specific β-subunit and an α-subunit which is common to FSH, LH, and TSH (Pierce and Parsons, 
1981). hCG is absolutely necessary for successful pregnancy. By binding to the LH/CG receptor, 
the most investigated role of the hormone is to keep up the production of steroid hormones in the 
corpus luteum until the seventh week of gestation before the luteoplacental shift in progesterone 
production takes place (Tulchinsky and Hobel, 1973).  
Recent research identified new roles for hCG, as more and more non gonadal cell types 
were found which express the LH/CG receptor such as placenta, uterus, breast and others. These 
findings suggest that the hormone may govern a multitude of biological processes in reproduction 
(Rao and Lei, 2007). Indeed, several groups found diverse effects of CG on fetal and maternal 
cells including enhancement of trophoblast differentiation, invasion and decidualization, inhibition 
of myometrial contractility, and promotion of uterine angiogenesis (Leisser et al., 2006; Prast et 
al., 2008; Shi et al., 1993; Strakova et al., 2005; Ticconi et al., 2007; Tulchinsky and Hobel, 1973; 
Zygmunt et al., 2002). 
 
 
1.4 SIGNALING PATHWAYS INVOLVED IN EXTRAVILLOUS TROPHOBLAST 
INVASION 
1.4.1 Introduction 
Signal transduction through sequential steps of phosphorylation is one of the most common 
control mechanisms of cellular protein function. Multiple extracellular stimuli such as growth 
factors, hormones, and cytokines or cell-matrix contacts can initiate signaling upon interaction 
with receptor tyrosine kinases (RTKs), G-protein-coupled receptors (GPCRs), integrins or others. 
This leads to the activation of signaling cascades such as mitogen-activated protein kinases 
(MAPKs), the PI3K/AKT pathway or Wnt-signaling pathway, controlling a wide range of 
biological processes including proliferation, differentiation, migration and invasion. Therefore, it 
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is not surprising that the different signaling pathways also play a critical role in trophoblast 
differentiation and invasion.  
 
1.4.2 Mitogen-activated protein kinases (MAPKs) 
The family of MAPKs consist of a large group of enzymes which are activated by phosphorylation 
at specific Sererin, Threonin and Tyrosin residues. Upon ligand binding to RTKs or GPCRs 
enzymes of the MAPK kinase kinase family (MEK), such as Raf, are activated through Ras. This 
leads to the activation of MAPK kinases, for example MEKs, which subsequently phosphorylate 
four different families of MAPK, i.e. extracellular regulated kinases (ERKs), ERK5, c-Jun N-
terminal kinases (JNKs) and different p38 MAPKs. Whereas ERKs are mainly activated through 
mitogenic signals, JNK and p38 MAPK are predominantly associated with stress and 
inflammatory response (Kyriakis and Avruch, 2001). 
 
1.4.3 Phosphoinositide-3-kinase (PI3K)/AKT-Signaling 
PI3K/AKT signaling is involved in many cellular processes including cell growth, proliferation, 
migration and survival (Manning and Cantley, 2007). Activation of RTKs or GPCRs results in 
membrane recruitment/activation of the p85 and p110 subunits of PI3K, respectively. Active PI3K 
phosphorylates phosphatidylinositol-4, 5-bis-phosphate (PIP2) and converts PIP2 to PIP3. 
Elevated PIP3 levels result in recruitment and activation of AKT at the membrane. After this, 
signaling is achieved by phosphorylation of downstream factors, for example mammalian target of 
rapamycin (mTOR) controlling protein synthesis, tumor suppressor protein p53 leading to either 
cell cycle arrest and DNA repair or apoptosis (Levine, 1997) or glycogen synthase kinase-3 (GSK-
3) whose activity can be inhibited by AKT-mediated phosphorylation (Cross et al., 1995; Pandey 
et al., 1998). AKT, however, also phosphorylates a wide range of other target proteins that control 
proliferation, cell growth and survival.  
Activation of PI3K/AKT signaling by factors such as EGF has also been described in 
human trophoblasts (Johnstone et al., 2005). AKT also seems to play a critical role in development 
and differentiation of trophoblasts. Homozygous deletion of AKT1 in mice affects placental 
development due to decreased numbers of proliferative trophoblasts (Yang et al., 2003). The role 
of AKT in cell migration is less understood. The three different AKT isoforms may positively or 
negatively influence motility depending on the cell type (Manning and Cantley, 2007). However, 
there is evidence from several laboratories suggesting that PI3K/AKT signaling affects human 
trophoblast motility. In particular, abundant growth factors like EGF and IGF-II, are potent 
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activators of PI3K/AKT and AKT-dependent motility of trophoblastic HTR-8/SVneo cells (Qiu et 
al., 2005; Qiu et al., 2004a). In SGHPL-5 cells activation of PI3K with specific peptides resulted 
in increased motility, whereas inhibition of PI3K reduced basal and HGF-induced migration 
(Cartwright et al., 2002b). Activation of AKT through hCG was noticed in purified EVT and 
SGHPL-5 cells (Prast et al., 2008). Inhibition of the signaling pathway reduced migration of 
SGHPL-5 cells and motility of EVT in villous explant cultures (Prast et al., 2008). PI3K/AKT is 
also required for hCG- and EGF-dependent expression of MMP-2 and MMP-9 in trophoblasts 
(Prast et al., 2008; Qiu et al., 2004b), as well as of MMP-3 (Husslein et al., 2009). 
 
1.4.4 Wnt-Signaling 
A small number of signaling pathways is used over and over again during evolution of life. Such 
crucial and conserved signaling pathways include Hedhoge, Tgf-β/Bmp, Notch and Wnt being 
active from drosophila to human (Beddington and Robertson, 1999; Capdevila and Izpisua 
Belmonte, 2001; Jessell and Sanes, 2000; Logan and Nusse, 2004; Schier and Talbot, 2005). 
Signaling by the Wnt family of secreted lipoproteins has central roles in embryogenesis and tissue 
homeostasis in adult organisms (Clevers, 2006; Logan and Nusse, 2004). Wnt ligands control stem 
cell functions and promote or inhibit differentiation depending on the cellular context (Ivanova et 
al., 2002; Ramalho-Santos et al., 2002; Sato et al., 2003; Walsh and Andrews, 2003). Abnormal 
Wnt signaling is often associated with severe human diseases, including cancer, osteoporosis and 
other degenerative disorders (Clevers, 2006; Logan and Nusse, 2004). Up to these days, 19 Wnt 
ligands, 10 Frizzled receptors (FZD) and 2 low density lipoprotein receptor related protein 
coreceptors (LRP5 and -6) have been identified in mammals (Wodarz and Nusse, 1998). Wnt 
signals can activate three different pathways, of which the canonical pathway is best characterized. 
In the canonical pathway the Wnt signal is transduced by Frizzled receptors and LRPs, regulating 
the stability of the transcriptional co-activator β-catenin and therefore β-catenin-dependent gene 
expression. Noncanonical Wnt signaling cascades, i.e. the β-catenin-independent Wnt/Ca++ and 
Wnt/planar cell polarity (PCP) pathways, are less understood. In the noncanonical pathways signal 
transduction occurs by binding of Wnts to FZDs without involvement of LRP or ß-catenin 
activation.  
The major player in canonical Wnt signaling is β-catenin. In the off state, the absence of 
Wnt ligands, β-catenin is complexed with APC (adenomatous polyposis coli) and Axin, both 
facilitating the phosophorlylation of β-catenin by casein kinase Iα (CKIα) and glycogen synthase 
kinase 3β (GSK3β), followed by continuous degradation through the β-TrCP (β-transducin repeat-
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containing protein) mediated ubiquitin/proteasome pathway (Figure 5, off-state) (Ikeda et al., 
1998; Liu et al., 2002). 
 
 
 
 
Figure 5 | Simplified overview 
of the canonical Wnt/β-pathway: 
(off-state) in the absence of Wnt 
ligand, β-catenin is bound in a 
multiprotein degradation 
complex containing the scaffold 
protein Axin, the tumour 
suppressor gene product APC, as 
well as the kinases CKI and 
GSK3β, among others. Upon 
phosphorylation, β-catenin is 
ubiquitinated by the β-TrCP–E3-
ligase complex and subsequently 
degraded by the proteasomes. 
(on-state) Wnt ligand associates 
with Frizzled and LRP5/6 co-
receptors. This leads to the 
translocation of Axin to the 
plasma membrane through direct 
interaction with LRP5/6 and 
Dsh/Frizzled. β-catenin is 
released from the multiprotein 
complex, accumulates in the 
cytoplasm in a non-
phosphorylated form, and subsequently translocates into the nucleus where it promotes transcription of Wnt target 
genes upon binding to TCF/LEF. 
 
Upon Wnt stimulation, the receptors FZD and LRP become close partners. This triggers a 
series of events that disrupts the Axin/APC/GSK3β/CK1α complex that is required for the 
destruction of β-catenin (Gordon and Nusse, 2006). The binding of Wnt ligands to the FZD/LRP 
receptor complex induces the recruitment of Dishevelled (Dsh) building a so called signalosome 
(Bilic et al., 2007) and the translocation of Axin, normally a key negative regulator of β-catenin 
stability to the membrane. Binding of Axin to the cytoplasmatic tail of LRP is catalysed by 
phosphorylation of LRP by either CK1γ or GSK3β (Mao et al., 2001; Zeng et al., 2008). It seems 
that in Wnt signaling cascades many proteins not only have one particular role, but can act either 
as a positive or negative regulator of signaling. Once these signalosome together with Axin is 
activated a complex series of events start, leading to the prevention of β-catenin degradation 
followed by stabilization and accumulation of the protein in the cytoplasm (Hatsell et al., 2003). 
The so stabilized β-catenin then translocates into the nucleus by a poorly understood mechanism 
(Figure 5, on-state). This could be an intrinsic property of β-catenin or an active process, 
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influenced by several factors (Henderson and Fagotto, 2002; Komiya and Habas, 2008). Once in 
the nucleus, β-catenin can act as a transcriptional co-regulator. There it displaces transcription 
inhibitors Graucho/histone deacetylases (HDACs) from the T cell-specific factor (TCF)/lymphoid 
enhancer-binding factor 1 (LEF1) and recruits histon acetylases and the Legless family docking 
Proteins (BCL9). Thus, this newly formed complex now binds to the promoter of target genes, 
including those involved in embryogenesis and oncogenesis. Also, genes of the Wnt pathway are 
induced such as Axin 2, FZDs, Dkk and several other components, indicating that feedback 
control is also a feature of Wnt signaling. 
The non-canonical pathway, also called β-catenin independent pathway, does not operate 
through β-catenin. In some cases it even can inhibit nuclear β-catenin activity (Ishitani et al., 
2003). This pathway has been less well characterized, due to the diverse interactions of the 
molecules involved. The non-canonical pathway can be further divided and classified by it’s 
potency in invoking different cascades, including the Wnt/PCP (Wnt/c-Jun N-terminal kinase 
(JNK) and Wnt/Rho) and Wnt/Ca++ signaling. The common link between these two pathways is 
their signaling through FZD receptors.  
Signaling in the WNT/PCP pathway, WNT proteins bind to FZD receptors followed by 
activating Rho/Rac small GTPase and JNK via Dsh to assist in the subsequent regulation of 
cytoskeletal organization and gene expression. Dsh is connected via Daam1 to downstream 
effector Rho and ROCK (Rho-Associated Kinase). Rac is directly activated by Dsh, which further 
activates JNK (Figure 6; Wnt/PCP).  
The second branch of the non-canonical signaling, the Wnt/Ca++ pathway was discovered 
by the fact of intracellular Ca++ release from ER upon stimulation by some Wnts (Kohn and 
Moon, 2005; Slusarski and Pelegri, 2007). Wnt/FZD signaling leads to Ca++ release through Dsh 
and G-proteins, in one case through activation of the phosphodiesterase PDE inhibiting PKG 
(cGMP-dependent protein kinase) which normally blocks the intracellular Ca++ release. (Ma and 
Wang, 2006). In the other case, upon Wnt stimulation, Dsh activates through PLC (phospholipase 
C) IP3 (inositol 1,4,5-trisphosphate), which leads to the release of intracellular Ca++. Intracellular 
Ca++ in turn activates CamKII (calcium/calmodulin-dependent kinase II) and Calcineurin. CamKII 
has the capability to activate TAK1 (TGFβ activated kinase) and NEMO (Nemo-like kinase) 
which can antagonize β-catenin/TCF signaling (Ishitani et al., 1999). The protein phosphatase 
calcineurin unmasks conserved nuclear localization sequences of NF-AT (nuclear factor of 
activated T cells) by dephosphorylation of critical regulatory aminoacids. This allows NF-AT to 
enter the nucleus and together with binding partners, such as members of the AP-1 family of 
transcription factors, activate gene expression (Boise et al., 1993). PLC has also the ability to 
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activate PKC (protein kinase C) through DAG (diacylglycerol) (Sheldahl et al., 2003) which in 
turn can regulate tissue separation during gastrulation via CDC42 (cell division cycle 42; GTP 
binding protein, 25kD) (Figure 6, Wnt/Ca2+) (Winklbauer et al., 2001). 
 
 
 
 
 
 
 
Figure 6 | Simplified overview 
of non-canonical pathways: 
(Wnt/ PCP pathway) The 
Wnt/PCP pathway is 
characterized by asymmetric 
distribution of Frizzled-
receptors, resulting in cell 
polarity and the activation of 
RhoA/Rock GTPases and JNK 
through Dishevelled and 
Dishevelled-associated activator 
of morphogenesis 1 (DAAM1). 
(Wnt/Ca2+ pathway) Activation 
of the Wnt-calcium pathway by 
interaction of Wnts with 
Frizzled-receptors increases 
intracellular calcium level and 
subsequently activates 
Calcineurin, calcium/ 
calmodulin-dependent protein 
kinase II (CAMKII) and protein 
kinase C (PKC). 
 
In the last years evidence accumulated that Wnt signaling could also be involved in 
placental development and trophoblast differentiation. Knock-out studies of Wnt2, Wnt7b and 
LEF-1/TCF in mice resulted in different placental pathologies. Wnt2 mutants have poorly 
developed labyrinth layers leading to defective placental vascular development with a reduced 
number of fetal-derived placental capillaries. For Wnt7b, which is expressed in the chorion, the 
mutants have a chorioallantoic attachment defect. And  LEF-1/TCF mutant mice  fail to form a 
placenta et all (Galceran et al., 1999; Monkley et al., 1996; Parr et al., 2001). Implantation in mice 
was shown to be associated with increased expression of Wnt4 and inhibition of canonical 
signaling impaired the process (Mohamed et al., 2005; Paria et al., 2001). Moreover, the group of 
Linda Giudice investigated the cycle-dependent expression of Dkk1 in human endometrial stroma, 
showing, that progesterone is an activator of Dkk1 expression. Their data suggest an equilibrium 
between active Wnt/β-catenin signaling in trophoblast invasion and the counterbalancing effect of 
inhibitory, endometrial Dkk1 expression (Tulac et al., 2006).  
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1.5 PATHOLOGIES IN PLACENTAL DEVELOPMENT 
The invasion of trophoblasts into the uterine wall is of fundamental importance for placental and 
fetal development. Arguably the most frequent causes for abnormal placentation are ectopic 
implantation, poor invasiveness or excessive invasiveness of trophoblasts.  
Implantation at other sites then along the posterior or anterior uterine wall can cause severe 
pathologies. Such ectopic implantation sites can be the uterine tube or near the uterine-cervical 
boundary. In both cases, severe bleeding can lead to death of the mother. Uterine tubal 
pregnancies never reach term because growth of the fetus is limited. Implantation at the uterine-
cervical boundary, also called placenta previa, can give rise to serious vaginal bleeding due to 
placental abruption at later stages of pregnancy. 
Preeclampsia as an example for poor invasiveness is a multifactorial and multiorgan 
disease, a hypertensive disorder specific to pregnancy and the major cause of maternal and 
neonatal mortality and morbidity. Here, abnormal invasion of trophoblasts occurs due to immune 
maladaptation of the mother and/or impaired placental perfusion and subsequent placental 
ischemia. This can result in proteinuria and transient hypertension in the 3rd trimester of 
pregnancy. Preeclamsia is often associated with fetal hypoxia and may lead to IUGR (Intrauterine 
growth restriction) of the fetus.  
On the other side there is the placental pathology called hydatidiform mole for excessive 
invasiveness of trophoblasts. Clinically, this pathology can be classified in complete (CHM) and 
partial hydatidiform moles (PHM) on the basis of histopathological features and the karyotype 
(Altieri et al., 2003). CHM emerges from a dispermic fertilization of the ovum with loss of the 
maternal chromosome. This results in diploid chromosomes, usually paternal XX. In CHM no 
embryo formation at all occurs, there is only placental tissue. The characteristics of these 
abnormal placentae are a mass of tissue with grape-like, swollen chorionic villi. The trophoblasts 
show an increased proliferation rate and are highly invasive. Such high proliferation/invasion rate 
may give rise to invasive gestational trophoblastic diseases. About 25% of CHMs have the 
potential to develop choriocarcinomas. Mole placentae can only be cured by surgical evacuation 
of uterine contents, followed by methotrexate (MTX) chemotherapy (in 10% of all cases) 
(Hammond and Evans, 1997). To be sure, that no persistent trophoblasts remain, monitoring of 
hCG up to one year after evacuation is necessary. Kato et al. (Kato et al., 2002) did gene 
expression profiling, utilising cDNA microarrays of CHM with the result that a large number of 
genes involved in cell growth and apoptosis were overexpressed. For me most interesting was the 
fact that one gene of the Wnt signaling pathway, Dsh-2, was found to be strongly upregulated and 
maybe is partaking in the development of CHM. 
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1.6 MODEL-SYSTEMS FOR TROPHOBLAST INVASION 
1.6.1 Trophoblast cell lines 
Several trophoblast cell lines were established, derived from first trimester placentae which are 
commonly used to study trophoblast invasion. 
There are three trophoblast-derived cell lines, HTR-8/SVneo cells, SGHPL-4 and SGHPL-
5 cells. Primary HTR-8/Svneo cell were obtained after plating and outgrowth of EVT from tissue 
pieces of first trimester villi after transfection with SV40 large T antigen and selection with 
neomycin. SGHPL-4 and SGHPL-5 cells have been produced after trypsinisation and gradient 
centrifugation of minced first trimester placentae (Choy and Manyonda, 1998; Choy et al., 2000). 
HTR-8/SVneo cells display an unlimited life-span in culture, whereas SGHPL-4 and SGHPL-5 
cells retained a senescence mechanism and are commonly used until passage 25 (G. Whitley, 
personal communication). The cell lines share features with invasive EVTs such as expression of 
cytokeratin 18 and some EVT-specific integrins (Graham et al., 1993). They express cytokeratin 7 
and HLA-G, particularly when plated on Matrigel®. SGHPL-4 cells still possess the feature of in 
vivo EVT, as they can invade fibrin-embedded spiral arteries (Cartwright et al., 2002a). 
Nevertheless differently to primary EVT in all trophoblast cell lines downregulation of cytokeratin 
7 and induction of vimentin was noticed, partly reflecting the conversion of an epithelial 
phenotype into a more fibroblastoid phenotype. Indeed, gene expression profiling and cluster 
analyses revealed that primary EVT share more similarities with villous CTB than with 
trophoblastic cell lines (M. Bilban and M. Knöfler, unpublished).  
 
1.6.2 Trophoblast primary cultures  
Considering the aspects of variances in all used cell lines, adoption of alternative model systems 
using primary cells may improve interpretation of in vitro data. Therefore two major concepts 
have been established in order to study extravillous trophoblast differentiation, invasion and 
migration. Either isolation of primary trophoblasts or cultivation of tips of placental villi on 
artificial matrices are utilized (Genbacev et al., 1992; Kliman et al., 1986).  
For cultivation of isolated primary trophoblasts, either first trimester placentae which are 
obtained from legal abortions or third trimester placentae which are obtained after delivery by 
Cesarean section can be used. Primary trophoblasts are prepared by trypsin digestion of the 
placental tissue, followed by percoll gradient centrifugation. Subsequently, several 
immunopurification steps are performed, including depletion of CD45-positive cells using an 
indirect-magnetic labelling approach (Figure 7) (Fisher et al., 1989); (Kliman et al., 1986).  
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Figure 7 | Simplified 
overview of isolation/ 
cultivation of primary 
trophoblasts: After 
trypsinisation and 
immuno purification, 
the obtained cyto-
trophoblasts can alter 
into different tropho-
blast subtypes, de-
pending on cultivation 
conditions. Seeded on 
Matrigel-coated dishes 
they will become 
EVTs. Seeded on 
plastic they will stay cytotrophoblasts a short period of time and later start to fuse into syncytiotrophoblasts. 
 
For cultivation of placental villi tips, called primary villous explant culture, first trimester placenta 
were dissected under the light microscope. Dissected villi are then seeded either on Matrigel or 
rat-tail collagen I, resulting in invasion into the Matrigel drop at the anchorage site or migration on 
top of the gel drop, respectively (Figure 8) (Caniggia et al., 1997; Genbacev et al., 1992). Similar 
to the situation in vivo, trophoblasts which invade into the Matrigel quit proliferation, change their 
integrin expression and up-regulate HLA-G. 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 | Simplified overview of villous 
explant cultures.  Dissected first trimester 
placental villi seeded either on Matrigel or 
Collagen I drops resulting in invasion or 
migration of EVTs, respectively. 
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1.7 AIM OF THE WORK 
The main focus of my work was to investigate new factors and signaling pathways governing 
extravillous trophoblast differentiation, migration and invasion. Earlier micro array studies of 
different trophoblast subtypes in early and late pregnancy (Bilban et al., 2009) and trophoblastic 
cell lines revealed a distinct expression pattern for genes involved in epithelial-mesenchymal 
transition (EMT) and Wnt signaling, namely TCFs. Since the overall focus of the laboratory is to 
investigate mechanisms controlling placental development, it was obvious to take a closer look at 
genes possibly governing these processes. 
My first step was to confirm the expression pattern of ligands and receptors involved in 
Wnt signaling pathways. Furthermore, I studied the changes of the expression pattern of Wnt 
signaling molecules during the progression of pregnancy in different tissue samples, primary cells 
and trophoblastic cell lines. In addition, I took a closer look at the antagonizing roles of canonical 
Wnt/β-catenin signaling versus non-canonical signaling pathways.  
The second scope of my work was focused on the interaction and outcome of two different 
signaling pathways in extravillous trophoblast migration and invasion, canonical Wnt/β-catenin 
signaling and PI3 kinase signaling, respectively. Using protein detection methods I started to 
characterise the impact of Wnt stimulation on the phosphorylation status of AKT and GSK-3β in 
primary cells and SGHPL-5 cells. Furthermore, I studied the translocation of β-catenin from the 
cytoplasm into the nucleus upon recombinant Wnt-3A stimulation, in presence of Dkk1 or 
LY294002 (PI3 kinase inhibitor). In addition, I performed functional assays using recombinant 
Wnt-3A and Dkk1 or LY294002 in order to study migration in SGHPL-5 cells and villous explant 
cultures. Finally, I investigated target genes related to invasiveness in trophoblasts which could be 
possibly regulated by Wnt and/or AKT signaling.  
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3. DISCUSSION 
A discussion with a strong focus on Wnt and PI3K/AKT signaling (Pollheimer et al., 2006; Prast 
et al., 2008; Sonderegger et al., 2009; Sonderegger et al., 2007) and unpublished, preliminary data 
will follow. 
 
3.1 SIGNALING CASCADES DURING EARLY PREGNANCY 
3.1.1 Wnt signaling, PI3K/AKT signaling and MMP 
The Wnt signaling pathway controls cell proliferation, stem cell maintenance and cell fate 
directions, as well as organized cell motility and the establishment of tissue polarity. All these 
decisions have also to be made during placental development. 14 out of 19 Wnt ligands and 8 out 
of 10 FZD receptors were expressed from first to third trimester (Sonderegger et al., 2007). These 
findings clearly point out, that there is a strong involvement of the Wnt pathway. Furthermore, 
previous data have shown that LRP-6 and Dkk1 are produced in placental tissue from first to third 
trimester (Pollheimer et al., 2006), suggesting multiple FZD/LRP-receptor complexes, which 
could transduce canonical Wnt signaling. The coexistence of members of the Dkk family 
(canonical Wnt inhibitory molecules) and their potential to decrease basal cell growth and 
migration in vitro lead to the conclusion that there has to be active canonical Wnt signaling. My 
study revealed that some Wnts (Wnt-1, -7b, -10a, -10b) are highly expressed in first trimester 
tissues suggesting a role in early placental differentiation. During gestation these partiuclar Wnt 
ligands decrease. In contrast, Wnt-5a is highly expressed in third trimester placentae compared to 
early ones. In addition, Wnt-10a and Wnt-10b were predominantly or exclusively expressed in 
CTBs, respectively. This may lead to the speculation that these two Wnts regulate basal 
proliferation in early placental development. The expression of FZD5 strongly decreased during 
invasive differentiation and may also control trophoblast growth together with Wnt-10a and Wnt-
10b. Furthermore, other Wnt ligands are abundantly expressed in EVT such as Wnt-1 or Wnt-2b, 
These two Wnts may control trophoblast migration and invasion. In addition, my data revealed 
that trophoblasts express ligands such as Wnt-4, Wnt-5a, Wnt-5b and Wnt-11, which are known to 
activate non-canonical signaling pathways independently of LRP-5/6 (Figure 9). One of these 
ligands, Wnt-5a was present in all trophoblast cell types. As it is known that Wnt-5a can activate 
the Ca2+-dependent Wnt pathway it may play a role as a negative regulator of trophoblast 
proliferation or invasion. Wnt-5a can regulate downstream signaling of CamKII, which has the 
capability to activate TAK1 and NEMO which in turn can antagonize β-catenin/TCF signaling 
(Ishitani et al., 1999). However, this has not yet been tested in trophoblast cells. I could show that 
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Wnt-5a impaired Wnt-3a-induced luciferase activity of pSuper(8x)TopFlash in SGHPL5-5 cells 
(Sonderegger et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 | Simplified 
overview of Wnt ligand and 
FZD receptor expression 
during gestation 
 
 The most interesting question was how Wnt signaling participates in trophoblast migration 
and invasion. Invasion is not a passive growth pressure against a permeable barrier it is an active 
biochemical process. A cell has to secrete proteases and to digest the blocking ECM to reach to 
promote invasiveness. This is a feature, which cancer cells and trophoblast cells have in common 
(Bischof and Campana, 2000; Bischof et al., 2000; Cohen and Bischof, 2007). Recent studies 
showed a connection between Wnt signaling and MMP expression in peripheral blood T cells and 
intestinal tumors (Brabletz et al., 1999; Crawford et al., 1999; Wu et al., 2007). My studies 
revealed a connection between Wnt signaling, PI3K/AKT signaling and MMP-2 secretion in 
trophoblast cells (Figure 10). Contrary to Wu et al., I could not detect any regulation of MMP-2 at 
the transcriptional level by real-time PCR or in MMP-2 reporter studies using EVT or SGHPL-5 
cells, respectively. However, not only Wnt signaling is controlling MMP-2 secretion in 
trophoblast cells, PI3K/AKT signaling participates strongly in this process. AKT was investigated 
because it may inactivate GSK-3β through phosphorylation at Ser9 and thereby increase stability 
of β-catenin and TCF-dependent transcription. Upon Wnt-3a stimulation AKT was 
phosphorylated independently of the presence of the canonical Wnt pathway inhibitor DKK1. The 
inhibitory effect of DKK1 is achieved by binding to the LRP5/6 co-receptor, an essential binding 
partner of FZD receptors in canonical signaling. These results clearly showed that activation of 
AKT cannot occur through the canonical Wnt receptor complex because DKK1 failed to inhibit 
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phosphorylation of AKT and in addition its downstream target GSK-3β. Moreover, in trophoblast 
cells inhibition of AKT failed to repress accumulation of active β-catenin or TCF reporter activity, 
even though AKT phosphorylated GSK-3β upon Wnt stimulation. Bearing this in mind it was 
obvious to conclude that in trophoblast cells activation of AKT upon Wnt-3a treatment must be 
transduced by LRP- independent receptors or receptor complexes and that inactivation of GSK-3β 
through phosphorylation is not involved in Wnt-dependent β-catenin stabilisation. Maybe other 
factors like Axin and its recruitment to the LRP-5/6-FZD receptor complex are sufficient for 
inhibition of the β-catenin destruction complex and to induce canonical Wnt signaling (Gordon 
and Nusse, 2006). 
 
 
 
 
 
 
 
 
Figure 10 | Current model system showing Wnt-
dependent pathways involved in trophoblast 
migration. The potential cross talk between Wnt and 
AKT is not critical in trophoblasts. The Wnt receptor 
promoting AKT phosphorylation in a LRP-5/6-
independent manner remains currently unknown. 
Wnt-3A-dependent activation of both signaling 
pathways results in elevated trophoblast migration 
and increased MMP-2 secretion. APC, Adenomatous 
polyposis coli; LY, LY294002. 
 
During the last few years some fundamental changes concerning Wnt signaling in receptor context 
occurred. First it was believed that only FZD and LRP-5/6-FZD receptors were capable of 
transducing Wnt signaling, culminating in the idea of the three well known Wnt pathways, the 
canonical Wnt/β-catenin, Wnt/Ca2+ and the Wnt/planar cell polarity pathway (Klaus and 
Birchmeier, 2008; Komiya and Habas, 2008). Moreover, Wnt ligands were assigned to transduce 
canonical or non-canonical signaling (Katoh, 2002; Katoh et al., 2001; Kohn and Moon, 2005; 
Merle et al., 2005; Takada et al., 2005; Wang et al., 2005). However, recent findings draw a 
different picture. There are now a plethora of new players in this game, new receptors, like Ror2, a 
RTK (receptor tyrosin kinase), or Ryk, also a RTK, which can act as stand alone receptors or as 
co-receptors in Wnt signaling (Kikuchi et al., 2009; van Amerongen and Nusse, 2009). They can 
inhibit β-catenin/TCF-signaling and activate JNK or SRC (Src family kinases). Sooner or later, 
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also the dogma of canonical and non-canonical Wnt ligands has to fall into oblivion. This was 
shown for Wnt-5a, which can act in the right receptor context as an activator of Wnt/β-catenin 
signaling in the presence of FZD4 and LRP5 (Mikels and Nusse, 2006), or for Wnt-11, which is 
also typically considered to be a non-canonical Wnt. Maternal contributed Wnt-11 can cause local 
accumulation of β-catenin in Xenopus embryo axis formation (Tao et al., 2005). 
All together, this shows the complexity of Wnt signaling suggesting that parcticular Wnt cascades 
should no longer be considered as linear pathways but as a Wnt network.  
 
3.1.2 Preliminary data - TCF-4  
Earlier data in our lab showed a distinct shift of expression of transcription factors and co-factor 
localisation in the out-growing CC of first trimester tissues. During out-growth and invasion, 
EVTs of the CC undergo a shift from a proliferate state into an invasive state. When this shift 
occurs, TCF4 a participant and target gene of the Wnt network, starts to be expressed, followed by 
translocation of β-catenin into the nucleus (page 50; Fig.2), suggesting activation of canonical 
Wnt signaling. Future perspectives are to identify target genes of the transcription factor in 
trophoblast cells. Therefore a stable TCF4 knock-down in SGHPL-5 cells was generated upon 
transduction with the miRNA adapted retroviral vector LMP (Open Biosystems). miRNA-adapted 
short hairpin RNA (shRNA) against human TCF4 generated in pSM2 vector (Open Biosystems) 
was subcloned into the LMP vector (Figure 11). 
Figure 11 | shRNAmir 
targeting human TCF4 
was shuttled from 
pSM2 into the 
retroviral vector LMP 
used to construct TCF4 
knockdown cells. 
Western blot analysis 
of shRNAmir control 
or TCF4 miRNA-
adapted short hairpin RNA transduced SGHPL-5 cells, shRNAmir TCF4, demonstrates the efficient TCF4 
knockdown. 
 
With these stable knock-down cells, genome-wide gene expression profiling will be performed for 
identification of TCF4 target genes. Furthermore, characterization of proliferation and cell 
invasion properties upon activation of canonical Wnt signaling will follow.  
 But not only loss of function studies for examining the role of TCF4 in trophoblast 
morphology will be up-coming in the laboratory. Gain of function studies will be performed. Due 
to the fact that EVT are more or less impossible to transfect, an adeno associated virus system, 
called AAV, was utilised to overexpress different TCF4 proteins; in detail, a functional wild type 
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TCF4 (WT-TCF4), a mutated dominant negative TCF4 (∆N-TCF4), lacking the β-catenin-
interacting domain and a dominant active TCF4 (∆N-VP16-TCF4), harboring the herpes simplex 
virus-encoded protein VP-16 a potent activator of immediate early transcription, were constructed 
(Wilson et al., 1997) (Figure 12).  
 
 
 
 
 
Figure 12 | Western blot analysis of AVV infected 
primary EVT, overexpressing WT-TCF4, ∆N-
TCF4, ∆N-VP16-TCF4; all harboring a FLAG-tag, 
AAV-mock was used as a control 
 
cDNA Micro arrays and Gene chip analyses (chromatin immunoprecipitation) of knock-
down TCF4 clones and EVTs overexpressing different TCF4 constructs may then reveal target 
genes which could possibly play major roles in trophoblast differentiation, proliferation, migration 
and invasion.  
 
 
 
Curriculum vitae 
 
 
90 
CURRICULIM VITAE 
 
 
 
 
 
 
 
Stefan Sonderegger 
 
 
 
 
 
 
 
 
 
Personal Data  Surname:   Sonderegger 
Name:   Stefan Eugen 
Nationality:   Austria 
 
Date of Birth: 21. 4. 1976 
Place of Birth: Feldkirch, Austria 
 
Address:   Brunnengasse 24/22 
A-1160 Wien 
Mobile:   +43-699-19414110 
 
e-mail:   stefan.eugen@gmx.at
 
 
 
 
 
 
 
 
 
 
 
 
       __________________________________ 
 
 
 
 
 
 
 
Curriculum vitae 
 
 
91 
 
    Experience & Education 
 
Current Position PhD-Student at the Dept. of Obstetrics and Fetal-Maternal 
Medicine, Medical University of Vienna 
    Group leader: Ao. Univ.-Prof. Mag. Dr. Martin Knöfler 
Thesis:  
The role of canonical Wnt-signaling during early trophoblast 
invasion 
 
2004-2005    Civilian service at “Fonds Soziales Wien”, Vienna 
 
2002-2004    Diploma student at the Dept. of Medical Biochemistry, 
Max F. Perutz Laboratories, University of Vienna.  
Group leader: Univ.-Prof. Dr. DI, Chair of Division of Molecular 
Cell Biology, Roland Foisner 
Thesis:  
deltaEF1 and Dnmt1: novel regulators of epithelial plasticity 
 
1995-2004  Study of Biology, Genetics/Microbiology at the University of 
Vienna 
 
1991-1995    University-entrance Diploma at High school, Feldkirch 
 
 
    International Awards 
 
2008 The Y. W. Loke New Investigator Travel Award 2008  
12th EPG Conference, International Federation of Placenta 
Associations Meeting,  
Sep. 10th -13th, 2008 Seggau Castle, Austria 
 
2006 The Y. W. Loke New Investigator Travel Award 2006  
12th International Federation of Placenta Associations 
Meeting,  
Sep. 6th-9th, 2006 Kobe, Japan 
 
 
    Languages & special Skills 
 
Languages   German (native), English (fluent) 
 
Supervision  of students during their diploma studies, early PhD students 
and technicians 
 
Computer skills  MS Office (Word, Excel, PowerPoint), Adobe Photoshop and 
Adobe Illustrator 
 
 
 
 
References 
 
 
92 
REFERENCES 
 
Altieri, A., Franceschi, S., Ferlay, J., Smith, J. and La Vecchia, C. (2003). Epidemiology and 
aetiology of gestational trophoblastic diseases. Lancet Oncol 4, 670-8. 
Bass, K. E., Morrish, D., Roth, I., Bhardwaj, D., Taylor, R., Zhou, Y. and Fisher, S. J. 
(1994). Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that 
paracrine factors modify this process. Dev Biol 164, 550-61. 
Bauer, S., Pollheimer, J., Hartmann, J., Husslein, P., Aplin, J. D. and Knofler, M. (2004). 
Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen 
activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 89, 812-
22. 
Beddington, R. S. and Robertson, E. J. (1999). Axis development and early asymmetry in 
mammals. Cell 96, 195-209. 
Bilban, M., Haslinger, P., Prast, J., Klinglmuller, F., Woelfel, T., Haider, S., Sachs, A., 
Otterbein, L. E., Desoye, G., Hiden, U. et al. (2009). Identification of novel trophoblast 
invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated 
receptor gamma. Endocrinology 150, 1000-13. 
Bilic, J., Huang, Y. L., Davidson, G., Zimmermann, T., Cruciat, C. M., Bienz, M. and 
Niehrs, C. (2007). Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 
phosphorylation. Science 316, 1619-22. 
Bischof, P. and Campana, A. (2000). A putative role for oncogenes in trophoblast invasion? 
Hum Reprod 15 Suppl 6, 51-8. 
Bischof, P. and Irminger-Finger, I. (2005). The human cytotrophoblastic cell, a mononuclear 
chameleon. Int J Biochem Cell Biol 37, 1-16. 
Bischof, P., Meisser, A. and Campana, A. (2000). Paracrine and autocrine regulators of 
trophoblast invasion--a review. Placenta 21 Suppl A, S55-60. 
Boise, L. H., Petryniak, B., Mao, X., June, C. H., Wang, C. Y., Lindsten, T., Bravo, R., 
Kovary, K., Leiden, J. M. and Thompson, C. B. (1993). The NFAT-1 DNA binding complex in 
activated T cells contains Fra-1 and JunB. Mol Cell Biol 13, 1911-9. 
Brabletz, T., Jung, A., Dag, S., Hlubek, F. and Kirchner, T. (1999). beta-catenin regulates the 
expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155, 1033-
8. 
References 
 
 
93 
Caniggia, I., Taylor, C. V., Ritchie, J. W., Lye, S. J. and Letarte, M. (1997). Endoglin 
regulates trophoblast differentiation along the invasive pathway in human placental villous 
explants. Endocrinology 138, 4977-88. 
Capdevila, J. and Izpisua Belmonte, J. C. (2001). Patterning mechanisms controlling vertebrate 
limb development. Annu Rev Cell Dev Biol 17, 87-132. 
Cartwright, J. E., Holden, D. P. and Whitley, G. S. (1999). Hepatocyte growth factor regulates 
human trophoblast motility and invasion: a role for nitric oxide. Br J Pharmacol 128, 181-9. 
Cartwright, J. E., Kenny, L. C., Dash, P. R., Crocker, I. P., Aplin, J. D., Baker, P. N. and 
Whitley, G. S. (2002a). Trophoblast invasion of spiral arteries: a novel in vitro model. Placenta 
23, 232-5. 
Cartwright, J. E., Tse, W. K. and Whitley, G. S. (2002b). Hepatocyte growth factor induced 
human trophoblast motility involves phosphatidylinositol-3-kinase, mitogen-activated protein 
kinase, and inducible nitric oxide synthase. Exp Cell Res 279, 219-26. 
Cauffman, G., De Rycke, M., Sermon, K., Liebaers, I. and Van de Velde, H. (2009). Markers 
that define stemness in ESC are unable to identify the totipotent cells in human preimplantation 
embryos. Hum Reprod 24, 63-70. 
Chen, C. P. and Aplin, J. D. (2003). Placental extracellular matrix: gene expression, deposition 
by placental fibroblasts and the effect of oxygen. Placenta 24, 316-25. 
Choy, M. Y. and Manyonda, I. T. (1998). The phagocytic activity of human first trimester 
extravillous trophoblast. Hum Reprod 13, 2941-9. 
Choy, M. Y., St Whitley, G. and Manyonda, I. T. (2000). Efficient, rapid and reliable 
establishment of human trophoblast cell lines using poly-L-ornithine. Early Pregnancy 4, 124-43. 
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-80. 
Cohen, M. and Bischof, P. (2007). Factors regulating trophoblast invasion. Gynecol Obstet Invest 
64, 126-30. 
Crawford, H. C., Fingleton, B. M., Rudolph-Owen, L. A., Goss, K. J., Rubinfeld, B., Polakis, 
P. and Matrisian, L. M. (1999). The metalloproteinase matrilysin is a target of beta-catenin 
transactivation in intestinal tumors. Oncogene 18, 2883-91. 
Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995). 
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 
785-9. 
Damsky, C. H., Fitzgerald, M. L. and Fisher, S. J. (1992). Distribution patterns of extracellular 
matrix components and adhesion receptors are intricately modulated during first trimester 
cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89, 210-22. 
References 
 
 
94 
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P. and Bellet, D. (2007). Molecular 
circuits shared by placental and cancer cells, and their implications in the proliferative, invasive 
and migratory capacities of trophoblasts. Hum Reprod Update 13, 121-41. 
Fisher, S. J., Cui, T. Y., Zhang, L., Hartman, L., Grahl, K., Zhang, G. Y., Tarpey, J. and 
Damsky, C. H. (1989). Adhesive and degradative properties of human placental cytotrophoblast 
cells in vitro. J Cell Biol 109, 891-902. 
Fitzgerald, J. S., Busch, S., Wengenmayer, T., Foerster, K., de la Motte, T., Poehlmann, T. 
G. and Markert, U. R. (2005). Signal transduction in trophoblast invasion. Chem Immunol 
Allergy 88, 181-99. 
Fukuda, M. N. and Sugihara, K. (2008). An integrated view of L-selectin and trophinin function 
in human embryo implantation. J Obstet Gynaecol Res 34, 129-36. 
Galceran, J., Farinas, I., Depew, M. J., Clevers, H. and Grosschedl, R. (1999). Wnt3a-/--like 
phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13, 709-17. 
Genbacev, O., Joslin, R., Damsky, C. H., Polliotti, B. M. and Fisher, S. J. (1996). Hypoxia 
alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the 
placental defects that occur in preeclampsia. J Clin Invest 97, 540-50. 
Genbacev, O., Schubach, S. A. and Miller, R. K. (1992). Villous culture of first trimester 
human placenta--model to study extravillous trophoblast (EVT) differentiation. Placenta 13, 439-
61. 
Genbacev, O. D., Prakobphol, A., Foulk, R. A., Krtolica, A. R., Ilic, D., Singer, M. S., Yang, 
Z. Q., Kiessling, L. L., Rosen, S. D. and Fisher, S. J. (2003). Trophoblast L-selectin-mediated 
adhesion at the maternal-fetal interface. Science 299, 405-8. 
Gordon, M. D. and Nusse, R. (2006). Wnt signaling: multiple pathways, multiple receptors, and 
multiple transcription factors. J Biol Chem 281, 22429-33. 
Graham, C. H., Hawley, T. S., Hawley, R. G., MacDougall, J. R., Kerbel, R. S., Khoo, N. and 
Lala, P. K. (1993). Establishment and characterization of first trimester human trophoblast cells 
with extended lifespan. Exp Cell Res 206, 204-11. 
Graham, C. H. and Lala, P. K. (1992). Mechanisms of placental invasion of the uterus and their 
control. Biochem Cell Biol 70, 867-74. 
Gude, N. M., Roberts, C. T., Kalionis, B. and King, R. G. (2004). Growth and function of the 
normal human placenta. Thromb Res 114, 397-407. 
Hamilton, G. S., Lysiak, J. J., Han, V. K. and Lala, P. K. (1998). Autocrine-paracrine 
regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-
binding protein (IGFBP)-1. Exp Cell Res 244, 147-56. 
References 
 
 
95 
Hammond, C. B. and Evans, A. C. (1997). Gestational trophoblastic disease. Curr Ther 
Endocrinol Metab 6, 603-6. 
Hatsell, S., Rowlands, T., Hiremath, M. and Cowin, P. (2003). Beta-catenin and Tcfs in 
mammary development and cancer. J Mammary Gland Biol Neoplasia 8, 145-58. 
Henderson, B. R. and Fagotto, F. (2002). The ins and outs of APC and beta-catenin nuclear 
transport. EMBO Rep 3, 834-9. 
Huber, A. V., Saleh, L., Bauer, S., Husslein, P. and Knofler, M. (2006). TNFalpha-mediated 
induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta 27, 127-36. 
Husslein, H., Haider, S., Meinhardt, G., Prast, J., Sonderegger, S. and Knofler, M. (2009). 
Expression, regulation and functional characterization of matrix metalloproteinase-3 of human 
trophoblast. Placenta 30, 284-91. 
Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. (1998). Axin, a 
negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-
catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Embo J 17, 1371-84. 
Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., 
Moon, R. T., Ninomiya-Tsuji, J. and Matsumoto, K. (2003). The TAK1-NLK mitogen-
activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-
catenin signaling. Mol Cell Biol 23, 131-9. 
Ishitani, T., Ninomiya-Tsuji, J., Nagai, S., Nishita, M., Meneghini, M., Barker, N., 
Waterman, M., Bowerman, B., Clevers, H., Shibuya, H. et al. (1999). The TAK1-NLK-
MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. 
Nature 399, 798-802. 
Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A. and Lemischka, I. R. 
(2002). A stem cell molecular signature. Science 298, 601-4. 
Jessell, T. M. and Sanes, J. R. (2000). Development. The decade of the developing brain. Curr 
Opin Neurobiol 10, 599-611. 
Johnstone, E. D., Mackova, M., Das, S., Payne, S. G., Lowen, B., Sibley, C. P., Chan, G. and 
Guilbert, L. J. (2005). Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. 
Placenta 26, 548-55. 
Kato, H. D., Terao, Y., Ogawa, M., Matsuda, T., Arima, T., Kato, K., Yong, Z. and Wake, N. 
(2002). Growth-associated gene expression profiles by microarray analysis of trophoblast of molar 
pregnancies and normal villi. Int J Gynecol Pathol 21, 255-60. 
Katoh, M. (2002). Regulation of WNT signaling molecules by retinoic acid during neuronal 
differentiation in NT2 cells: threshold model of WNT action (review). Int J Mol Med 10, 683-7. 
References 
 
 
96 
Katoh, M., Kirikoshi, H., Terasaki, H. and Shiokawa, K. (2001). WNT2B2 mRNA, up-
regulated in primary gastric cancer, is a positive regulator of the WNT- beta-catenin-TCF 
signaling pathway. Biochem Biophys Res Commun 289, 1093-8. 
Kikuchi, A., Yamamoto, H. and Sato, A. (2009). Selective activation mechanisms of Wnt 
signaling pathways. Trends Cell Biol 19, 119-29. 
Klaus, A. and Birchmeier, W. (2008). Wnt signalling and its impact on development and cancer. 
Nat Rev Cancer 8, 387-98. 
Kliman, H. J., Nestler, J. E., Sermasi, E., Sanger, J. M. and Strauss, J. F., 3rd. (1986). 
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term 
placentae. Endocrinology 118, 1567-82. 
Kohn, A. D. and Moon, R. T. (2005). Wnt and calcium signaling: beta-catenin-independent 
pathways. Cell Calcium 38, 439-46. 
Komiya, Y. and Habas, R. (2008). Wnt signal transduction pathways. Organogenesis 4, 68-75. 
Kyriakis, J. M. and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal 
transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-69. 
Leisser, C., Saleh, L., Haider, S., Husslein, H., Sonderegger, S. and Knofler, M. (2006). 
Tumour necrosis factor-alpha impairs chorionic gonadotropin beta-subunit expression and cell 
fusion of human villous cytotrophoblast. Mol Hum Reprod 12, 601-9. 
Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-31. 
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X. and He, X. 
(2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 
108, 837-47. 
Logan, C. Y. and Nusse, R. (2004). The Wnt signaling pathway in development and disease. 
Annu Rev Cell Dev Biol 20, 781-810. 
Ma, L. and Wang, H. Y. (2006). Suppression of cyclic GMP-dependent protein kinase is 
essential to the Wnt/cGMP/Ca2+ pathway. J Biol Chem 281, 30990-1001. 
Manning, B. D. and Cantley, L. C. (2007). AKT/PKB signaling: navigating downstream. Cell 
129, 1261-74. 
Mao, J., Wang, J., Liu, B., Pan, W., Farr, G. H., 3rd, Flynn, C., Yuan, H., Takada, S., 
Kimelman, D., Li, L. et al. (2001). Low-density lipoprotein receptor-related protein-5 binds to 
Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7, 801-9. 
Merle, P., Kim, M., Herrmann, M., Gupte, A., Lefrancois, L., Califano, S., Trepo, C., 
Tanaka, S., Vitvitski, L., de la Monte, S. et al. (2005). Oncogenic role of the frizzled-7/beta-
catenin pathway in hepatocellular carcinoma. J Hepatol 43, 854-62. 
References 
 
 
97 
Mikels, A. J. and Nusse, R. (2006). Purified Wnt5a protein activates or inhibits beta-catenin-TCF 
signaling depending on receptor context. PLoS Biol 4, e115. 
Mohamed, O. A., Jonnaert, M., Labelle-Dumais, C., Kuroda, K., Clarke, H. J. and Dufort, 
D. (2005). Uterine Wnt/beta-catenin signaling is required for implantation. Proc Natl Acad Sci U S 
A 102, 8579-84. 
Monkley, S. J., Delaney, S. J., Pennisi, D. J., Christiansen, J. H. and Wainwright, B. J. 
(1996). Targeted disruption of the Wnt2 gene results in placentation defects. Development 122, 
3343-53. 
Pandey, S. K., Anand-Srivastava, M. B. and Srivastava, A. K. (1998). Vanadyl sulfate-
stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is 
independent of insulin receptor tyrosine phosphorylation. Biochemistry 37, 7006-14. 
Paria, B. C., Ma, W., Tan, J., Raja, S., Das, S. K., Dey, S. K. and Hogan, B. L. (2001). 
Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally 
applied growth factors. Proc Natl Acad Sci U S A 98, 1047-52. 
Parr, B. A., Cornish, V. A., Cybulsky, M. I. and McMahon, A. P. (2001). Wnt7b regulates 
placental development in mice. Dev Biol 237, 324-32. 
Pierce, J. G. and Parsons, T. F. (1981). Glycoprotein hormones: structure and function. Annu 
Rev Biochem 50, 465-95. 
Pollheimer, J. and Knofler, M. (2005). Signalling pathways regulating the invasive 
differentiation of human trophoblasts: a review. Placenta 26 Suppl A, S21-30. 
Pollheimer, J., Loregger, T., Sonderegger, S., Saleh, L., Bauer, S., Bilban, M., Czerwenka, 
K., Husslein, P. and Knofler, M. (2006). Activation of the canonical wingless/T-cell factor 
signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 168, 
1134-47. 
Prast, J., Saleh, L., Husslein, H., Sonderegger, S., Helmer, H. and Knofler, M. (2008). Human 
chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase 
and AKT signaling. Endocrinology 149, 979-87. 
Qiu, Q., Basak, A., Mbikay, M., Tsang, B. K. and Gruslin, A. (2005). Role of pro-IGF-II 
processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci U S A 
102, 11047-52. 
Qiu, Q., Yang, M., Tsang, B. K. and Gruslin, A. (2004a). Both mitogen-activated protein kinase 
and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced 
human trophoblast migration. Mol Hum Reprod. 
References 
 
 
98 
Qiu, Q., Yang, M., Tsang, B. K. and Gruslin, A. (2004b). EGF-induced trophoblast secretion of 
MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. 
Reproduction 128, 355-63. 
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C. and Melton, D. A. (2002). 
"Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298, 597-600. 
Rao, C. V. and Lei, Z. M. (2007). The past, present and future of nongonadal LH/hCG actions in 
reproductive biology and medicine. Mol Cell Endocrinol 269, 2-8. 
Red-Horse, K., Kapidzic, M., Zhou, Y., Feng, K. T., Singh, H. and Fisher, S. J. (2005). 
EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the 
human placenta into the maternal circulation. Development 132, 4097-106. 
Ruoslahti, E. (1996). RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 
12, 697-715. 
Sato, N., Sanjuan, I. M., Heke, M., Uchida, M., Naef, F. and Brivanlou, A. H. (2003). 
Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 
260, 404-13. 
Schier, A. F. and Talbot, W. S. (2005). Molecular genetics of axis formation in zebrafish. Annu 
Rev Genet 39, 561-613. 
Sheldahl, L. C., Slusarski, D. C., Pandur, P., Miller, J. R., Kuhl, M. and Moon, R. T. (2003). 
Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol 161, 769-
77. 
Shi, Q. J., Lei, Z. M., Rao, C. V. and Lin, J. (1993). Novel role of human chorionic 
gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 132, 1387-95. 
Slusarski, D. C. and Pelegri, F. (2007). Calcium signaling in vertebrate embryonic patterning 
and morphogenesis. Dev Biol 307, 1-13. 
Sonderegger, S., Haslinger, P., Sabri, A., Leisser, C., Otten, J. V., Fiala, C. and Knofler, M. 
(2009). Wingless (Wnt)-3A Induces Trophoblast Migration and Matrix Metalloproteinase-2 
Secretion through Canonical Wnt Signaling and Protein Kinase B/AKT Activation. 
Endocrinology. 
Sonderegger, S., Husslein, H., Leisser, C. and Knofler, M. (2007). Complex expression pattern 
of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 28 
Suppl A, S97-102. 
Strakova, Z., Mavrogianis, P., Meng, X., Hastings, J. M., Jackson, K. S., Cameo, P., 
Brudney, A., Knight, O. and Fazleabas, A. T. (2005). In vivo infusion of interleukin-1beta and 
References 
 
 
99 
chorionic gonadotropin induces endometrial changes that mimic early pregnancy events in the 
baboon. Endocrinology 146, 4097-104. 
Stupack, D. G. and Cheresh, D. A. (2002). Get a ligand, get a life: integrins, signaling and cell 
survival. J Cell Sci 115, 3729-38. 
Takada, R., Hijikata, H., Kondoh, H. and Takada, S. (2005). Analysis of combinatorial effects 
of Wnts and Frizzleds on beta-catenin/armadillo stabilization and Dishevelled phosphorylation. 
Genes Cells 10, 919-28. 
Tao, Q., Yokota, C., Puck, H., Kofron, M., Birsoy, B., Yan, D., Asashima, M., Wylie, C. C., 
Lin, X. and Heasman, J. (2005). Maternal wnt11 activates the canonical wnt signaling pathway 
required for axis formation in Xenopus embryos. Cell 120, 857-71. 
Ticconi, C., Zicari, A., Belmonte, A., Realacci, M., Rao Ch, V. and Piccione, E. (2007). 
Pregnancy-promoting actions of HCG in human myometrium and fetal membranes. Placenta 28 
Suppl A, S137-43. 
Tulac, S., Overgaard, M. T., Hamilton, A. E., Jumbe, N. L., Suchanek, E. and Giudice, L. C. 
(2006). Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human 
endometrial stromal cells. J Clin Endocrinol Metab 91, 1453-61. 
Tulchinsky, D. and Hobel, C. J. (1973). Plasma human chorionic gonadotropin, estrone, 
estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early 
normal pregnancy. Am J Obstet Gynecol 117, 884-93. 
van Amerongen, R. and Nusse, R. (2009). Towards an integrated view of Wnt signaling in 
development. Development 136, 3205-14. 
Walsh, J. and Andrews, P. W. (2003). Expression of Wnt and Notch pathway genes in a 
pluripotent human embryonal carcinoma cell line and embryonic stem cell. Apmis 111, 197-210; 
discussion 210-1. 
Wang, H. and Dey, S. K. (2006). Roadmap to embryo implantation: clues from mouse models. 
Nat Rev Genet 7, 185-99. 
Wang, Z., Shu, W., Lu, M. M. and Morrisey, E. E. (2005). Wnt7b activates canonical signaling 
in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. 
Mol Cell Biol 25, 5022-30. 
Wilson, A. C., Freiman, R. N., Goto, H., Nishimoto, T. and Herr, W. (1997). VP16 targets an 
amino-terminal domain of HCF involved in cell cycle progression. Mol Cell Biol 17, 6139-46. 
Winklbauer, R., Medina, A., Swain, R. K. and Steinbeisser, H. (2001). Frizzled-7 signalling 
controls tissue separation during Xenopus gastrulation. Nature 413, 856-60. 
References 
 
 
100 
Wodarz, A. and Nusse, R. (1998). Mechanisms of Wnt signaling in development. Annu Rev Cell 
Dev Biol 14, 59-88. 
Wu, B., Crampton, S. P. and Hughes, C. C. (2007). Wnt signaling induces matrix 
metalloproteinase expression and regulates T cell transmigration. Immunity 26, 227-39. 
Yang, Z. Z., Tschopp, O., Hemmings-Mieszczak, M., Feng, J., Brodbeck, D., Perentes, E. 
and Hemmings, B. A. (2003). Protein kinase B alpha/AKT1 regulates placental development and 
fetal growth. J Biol Chem 278, 32124-31. 
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., 
Doble, B., Woodgett, J. et al. (2008). Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 
phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135, 367-75. 
Zygmunt, M., Herr, F., Keller-Schoenwetter, S., Kunzi-Rapp, K., Munstedt, K., Rao, C. V., 
Lang, U. and Preissner, K. T. (2002). Characterization of human chorionic gonadotropin as a 
novel angiogenic factor. J Clin Endocrinol Metab 87, 5290-6. 
 
 
